Notice Number: NOT-DA-14-004
Key Dates
Release Date: January 24, 2014
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
This Notice replaces NOT-DA-13-002 to update the catalog of research cigarettes and ordering guidelines from the NIDA Drug Supply Program.
This Notice communicates the availability and procedures for acquisition of nicotine research cigarettes (NRC) through the NIDA Drug Supply Program (DSP). Information provided in this Notice will help the NIDA DSP and research investigators interested in tobacco research effectively plan for the use of NRCs and for responses to Funding Opportunity Announcements.
Limited quantities of NRCs manufactured under the NIDA DSP are available to research investigators under specified parameters such as nicotine and tar yields ,and type as reduced nicotine (RN), reduced nicotine and menthol (RN-Men), reduced nicotine and high tar (RN-HT), reduced nicotine, high tar and menthol (RN-HT-Men), and conventional nicotine (CN). The NIDA DSP will consider requests for its current inventory of NRCs from researcher investigators funded through the NIH to conduct tobacco science research.
To facilitate planning for either usage of the current inventory of NRCs, or future manufacturing needs, the NIDA DSP requests that research investigators who intend to submit requests for NRCs from the NIDA DSP send an email request with the following information: 1) anticipated total quantity (carton) of each type of NRC needed with their Tobacco Product Master File (TPMF) codes and Type, 2) the requested timeline and amounts for initial receipt, and 3) requested timeline of replenishment of each type of NRC. For those research investigators who have NIDA/NIH grants, they can submit their request according to the NIDA DSP Guidelines for Research Chemicals, Controlled Substances, and Nicotine Research Cigarettes (NRC). For more information, please email [email protected]
Characteristics of the NRC inventory are described in the following table:
TPMF Code |
Type |
Specifications |
Specifications |
NRC 100 |
RN-HV |
0.02 0.01 |
3 1.5 |
NRC 101 |
RN-HV-Men |
0.02 0.01 |
3 1.5 |
NRC 102 |
RN |
0.03 0.01 |
9 1.5 |
NRC 103 |
RN-Men |
0.03 0.01 |
9 1.5 |
NRC 104 |
RN-Men |
0.04 0.02 |
13 2 |
NRC 105 |
RN-HT-Men |
0.04 0.02 |
13 2 |
NRC 200 |
RN |
0.07 0.02 |
9 1.5 |
NRC 201 |
RN-Men |
0.07 0.02 |
9 1.5 |
NRC 300 |
RN |
0.12 0.03 |
9 1.5 |
NRC 301 |
RN-Men |
0.12 0.03 |
9 1.5 |
NRC 302 |
RN-HT-Men |
0.16 0.03 |
13 2 |
NRC 400 |
RN |
0.26 0.06 |
9 1.5 |
NRC 401 |
RN-Men |
0.26 0.06 |
9 1.5 |
NRC 402 |
RN-HT |
0.33 0.06 |
13 2 |
NRC 405 |
RN-HT-Men |
0.4 0.08 |
13 2 |
NRC 404 |
RN-HT |
0.6 0.12 |
13 2 |
NRC 500 |
RN-HT |
0.7 0.15 |
13 2 |
NRC 501 |
RN-Men |
0.6 0.12 |
9 1.5 |
NRC 600 |
CN |
0.8 0.15 |
10.5 1.5 |
NRC 601 |
CN-Men |
0.8 0.15 |
10.5 1.5 |
NRC 602 |
CN-HT-Men |
1.1 0.2 |
16 2 |
NRC 700 |
LTNR-HT |
1.6 0.3 |
16 2 |
NRC 701 |
LTNR-Men |
1.2 0.2 |
12 2 |
*Legend: |
|||
RN-HV |
Reduced Nicotine-High Ventilation |
||
RN-HV-Men |
Reduced Nicotine-High Ventilation Menthol |
||
RN |
Reduced Nicotine |
||
RN-Men |
Reduced Nicotine-Menthol |
||
RN-HT |
Reduced Nicotine-High Tar |
||
RN-HT-Men |
Reduced Nicotine-High Tar-Menthol |
||
CN |
Conventional Nicotine |
||
CN-Men |
Conventional Nicotine-Menthol |
||
CN-HT-Men |
Conventional Nicotine-High Tar-Menthol |
||
LTNR-HT |
Low Tar/Nicotine Ratio-High Tar |
||
LTNR-Men |
Low Tar/Nicotine Ratio-Menthol |
Inquiries
Please direct all inquiries to:
Hari H. Singh, PhD/ Phylicia Porter, MPH
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1310/ 301-435-1692
Email: [email protected]